Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aren van Waarde

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammationAren van Waarde, Pieter L Jager, Kiichi Ishiwata, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2008
Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulationAnna A Rybczynska, Rudi A Dierckx, Kiichi Ishiwata, et al.
Seminars in Nuclear Medicine|January 27, 2021
PET Agents in Dementia: An OverviewAren van Waarde, Sofia Marcolini, Peter Paul de Deyn, et al.
International Journal of Molecular Sciences|July 30, 2020
Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging PerspectiveGonçalo S Clemente, Aren van Waarde, Inês F Antunes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2006
Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cellsAren van Waarde, Lukas B Been, Kiichi Ishiwata, et al.
Neurochemistry International|June 24, 2008
Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors-the cases of ketamine and haloperidolRudie Kortekaas, R Paul Maguire, Aren van Waarde, et al.
Neurochemistry International|October 27, 2007
Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PETAren van Waarde, Janine Doorduin, Johan R de Jong, et al.
Methods (San Diego, Calif.)|August 17, 2002
Positron emission tomography: the conceptual idea using a multidisciplinary approachAnne M J Paans, Aren van Waarde, Philip H Elsinga, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 7, 2004
In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulattaRudie Kortekaas, R Paul Maguire, Thomas I Cremers, et al.
Journal of Neuroscience Research|August 4, 2021
Is cyclooxygenase-1 involved in neuroinflammation?Nafiseh Ghazanfari, Aren van Waarde, Rudi A J O Dierckx, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammationAren van Waarde, Pieter L Jager, Kiichi Ishiwata, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2008
Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulationAnna A Rybczynska, Rudi A Dierckx, Kiichi Ishiwata, et al.
Seminars in Nuclear Medicine|January 27, 2021
PET Agents in Dementia: An OverviewAren van Waarde, Sofia Marcolini, Peter Paul de Deyn, et al.
International Journal of Molecular Sciences|July 30, 2020
Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging PerspectiveGonçalo S Clemente, Aren van Waarde, Inês F Antunes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2006
Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cellsAren van Waarde, Lukas B Been, Kiichi Ishiwata, et al.
Neurochemistry International|June 24, 2008
Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors-the cases of ketamine and haloperidolRudie Kortekaas, R Paul Maguire, Aren van Waarde, et al.
Neurochemistry International|October 27, 2007
Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PETAren van Waarde, Janine Doorduin, Johan R de Jong, et al.
Methods (San Diego, Calif.)|August 17, 2002
Positron emission tomography: the conceptual idea using a multidisciplinary approachAnne M J Paans, Aren van Waarde, Philip H Elsinga, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 7, 2004
In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulattaRudie Kortekaas, R Paul Maguire, Thomas I Cremers, et al.
Journal of Neuroscience Research|August 4, 2021
Is cyclooxygenase-1 involved in neuroinflammation?Nafiseh Ghazanfari, Aren van Waarde, Rudi A J O Dierckx, et al.
Pageof 11